Aripiprazole Open-Label, Safety and Tolerability Study
Public ClinicalTrials.gov record NCT00102518. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label, Safety and Tolerability Study of Flexible-Dose Oral Aripiprazole (2 Mg-30 mg) in the Treatment of Adolescent Patients With Schizophrenia and Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to test the long-term safety and tolerability of aripiprazole in adolescent patients with schizophrenia, and child and adolescent patients with bipolar I disorder, manic or mixed episode.
Study identification
- NCT ID
- NCT00102518
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 325 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2004 (Type not available)
- Primary completion
- Feb 2007 (Actual)
- Completion
- Feb 2007 (Actual)
- Last update posted
- Aug 31, 2012
2004 – 2007
United States locations
- U.S. sites
- 50
- U.S. states
- 24
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Birmingham | Alabama | — | — |
| Local Institution | Little Rock | Arkansas | — | — |
| Local Institution | Costa Mesa | California | — | — |
| Local Institution | Fresno | California | — | — |
| Local Institution | Orange | California | — | — |
| Local Institution | Riverside | California | — | — |
| Local Institution | Rosemead | California | — | — |
| Local Institution | Sacramento | California | — | — |
| Local Institution | Temecula | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Altamonte Springs | Florida | — | — |
| Local Institution | Fort Lauderdale | Florida | — | — |
| Local Institution | Hialeah | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | Miami | Florida | — | — |
| Local Institution | Orange City | Florida | — | — |
| Local Institution | Tampa | Florida | — | — |
| Local Institution | Atlanta | Georgia | — | — |
| Local Institution | Honolulu | Hawaii | — | — |
| Local Institution | Chicago | Illinois | — | — |
| Local Institution | Kansas City | Kansas | — | — |
| Local Institution | Lexington | Kentucky | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Lake Charles | Louisiana | — | — |
| Local Institution | Metairie | Louisiana | — | — |
| Local Institution | New Orleans | Louisiana | — | — |
| Local Institution | Somerville | Massachusetts | — | — |
| Local Institution | Clinton | Michigan | — | — |
| Local Institution | Kansas City | Missouri | — | — |
| Local Institution | Saint Charles | Missouri | — | — |
| Local Institution | Elmsford | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Olean | New York | — | — |
| Local Institution | Rochester | New York | — | — |
| Local Institution | Chapel Hill | North Carolina | — | — |
| Local Institution | Cleveland | Ohio | — | — |
| Local Institution | Lyndhurst | Ohio | — | — |
| Local Institution | Oklahoma City | Oklahoma | — | — |
| Local Institution | Bala-Cynwyd | Pennsylvania | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Bellaire | Texas | — | — |
| Local Institution | DeSoto | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | San Antonio | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Kirkland | Washington | — | — |
| Local Institution | Seattle | Washington | — | — |
| Local Institution | Spokane | Washington | — | — |
| Local Institution | Wauwatosa | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00102518, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 31, 2012 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00102518 live on ClinicalTrials.gov.